Skip to main content

The Role of Laboratory Medicine in the Detection of Ethylene Glycol Poisoning

From the 2021 Joint Annual Meeting (recorded 6/28/2021)
Presented by Christopher Swartz, PhD, MLS (ASCP)

The session will examine the role of laboratory medicine in the clinical diagnosis of ethylene glycol poisoning. Direct and indirect methods of detection will be discussed, and case studies highlighting the use of laboratory medicine to assist in diagnosis will be presented.

At the conclusion of this presentation, participants will be able to:

  • Associate clinical presentation and testing anomalies in the clinical laboratory that may be suggestive of ethylene glycol poisoning of a patient.
  • Summarize the metabolic pathway for ethylene glycol poisoning, and associated medical treatments for this condition.
  • Identify screening and confirmatory testing methodologies for qualitative and quantitative determinations of ethylene glycol and potential metabolites.

ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of Chemistry will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

This Basic-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.